PlainRecalls
FDA Drug Low Class III Terminated

Mozobil (plerixafor injection) 24 mg/1.2 mL (20 mg/mL) per vial, Rx Only, For Subcutaneous Injection only, Manufactured by: Genzyme Corporation, 500 Kendall Street, Cambridge, MA 02142 A Sanofi Company Country of Origin : United Kingdom, NDC 0024-5862-01

Reported: September 28, 2016 Initiated: August 4, 2016 #D-1518-2016

Product Description

Mozobil (plerixafor injection) 24 mg/1.2 mL (20 mg/mL) per vial, Rx Only, For Subcutaneous Injection only, Manufactured by: Genzyme Corporation, 500 Kendall Street, Cambridge, MA 02142 A Sanofi Company Country of Origin : United Kingdom, NDC 0024-5862-01

Reason for Recall

Labeling: Incorrect or Missing Lot and/or Exp. Date

Details

Units Affected
9,530 vials
Distribution
nationwide
Location
Ridgefield, NJ

Frequently Asked Questions

What product was recalled?
Mozobil (plerixafor injection) 24 mg/1.2 mL (20 mg/mL) per vial, Rx Only, For Subcutaneous Injection only, Manufactured by: Genzyme Corporation, 500 Kendall Street, Cambridge, MA 02142 A Sanofi Company Country of Origin : United Kingdom, NDC 0024-5862-01. Recalled by Genzyme Corporation / Genzyme Biosurgery. Units affected: 9,530 vials.
Why was this product recalled?
Labeling: Incorrect or Missing Lot and/or Exp. Date
Which agency issued this recall?
This recall was issued by the FDA Drug on September 28, 2016. Severity: Low. Recall number: D-1518-2016.